Orbenin (Cloxacillin)

Cloxacillin, the active ingredient in Orbenin, is a beta‑lactam antibiotic presented as a strength/form for oral use. It treats infections caused by penicillin‑resistant staphylococci in adults and children. GNH USA supplies Orbenin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Orbenin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orbenin is a beta‑lactam antibiotic that targets bacterial infections of the skin and soft tissues.

- Cellulitis: Reduces bacterial load and promotes healing of inflamed skin. - Impetigo: Clears Staphylococcus‑driven lesions and prevents spread. - Osteomyelitis (adjunct therapy): Assists in eradicating resistant staphylococcal infection in bone tissue. - Septic arthritis: Contributes to bacterial clearance in joint infections. - Surgical prophylaxis: Provides coverage against penicillin‑resistant staphylococci during operative procedures.

Cloxacillin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Rash - Elevated liver enzymes - Headache

Serious or Rare Side Effects: - Anaphylaxis - Stevens‑Johnson syndrome - Hemolytic anemia - Severe neutropenia - Acute interstitial nephritis

Before using Orbenin, consider the following safety measures:

- Allergy assessment: Check the risk of beta‑beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta beta ...  - Liver function monitoring:  - Renal treatment ...  - Drug interaction review ...  - Pregnancy ...  - Store at room temperature : keep the product in the original pack and protect from moist the ... 

CPro  

t  t \